Transurethral resection of the prostate in the anticoagulated patient

    loading  Checking for direct PDF access through Ovid

Abstract

Objective

To assess the safety of transurethral prostatectomy (TURP) in patients on long-term full anticoagulation.

Patients and methods

Twelve TURPs were performed on 11 patients with urinary retention or severe symptoms from prostatic obstruction who also required anticoagulation for a history of life-threatening thromboembolic disease (seven) or prosthetic heart valves (four). Patients stopped taking warfarin 3 days before surgery; on admission a day later, full intravenous heparinization was commenced. Heparin was stopped 4 h before TURP and re-commenced with an initial bolus in the recovery room, and warfarin re-started that evening.

Results

The mean weight of prostate resected was 23 g and the mean peri-operative decrease in haemoglobin was 1.6 g/dL. Only one patient required a transfusion of 3 units, but the activated partial thromboplastin time (APTT) had risen to>4. The mean pre- and post-operative APTT were 1.7 and 2.64, respectively, and the mean total length of hospital stay 6.7 days. Three patients were re-admitted for secondary haemorrhage at 8, 9 and 28 days after TURP, but all resolved with catheterization for 24h only. There were no other major complications or thrombo-embolic phenomena.

Conclusion

TURP can be conducted safely in this high-risk group of patients with a regimen that allows a brief but controlled interruption to their full anticoagulation. This protects from the risks of thrombo-embolic incidents with no major increase in haemorrhage or hospital stay.

Related Topics

    loading  Loading Related Articles